Physician profile
Uplekh S Purewal
NPI 1548203839
$20,933.40
in general payments reported to CMS, 2019-2025
34 companies · $2,812 in 2025
The $2,812 reported for 2025 was more than what 85% of Pain Medicine providers received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,041 · 2020: $1,029 · 2021: $1,689 · 2022: $1,761 · 2023: $1,803 · 2024: $2,798 · 2025: $2,812.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,342 · Education: $65.98 · Travel and Lodging: $5.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,341.99 |
| Education | $65.98 |
| Travel and Lodging | $5.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $7,449.99 | 2019-2025 | Proclaim, Octrode, Eterna |
| Horizon Therapeutics Plc | $2,967.76 | 2019 | |
| Vertiflex, INC. | $2,643.63 | 2019 | |
| Nevro Corp. | $2,600.32 | 2019-2024 | Senza |
| Boston Scientific Corporation | $921.48 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Pacira Therapeutics, INC. | $603.48 | 2019 | |
| Globus Medical, INC. | $594.37 | 2025 | Senza, Vyrsa V1 |
| Vertos Medical, INC. | $551.25 | 2019-2021 | |
| Curonix LLC | $417.81 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medtronic, INC. | $368.15 | 2021-2025 | Inceptiv, Intellis Adaptivestim |
| Mml US, INC. | $346.84 | 2023-2025 | Reactiv8 |
| Biotronik INC. | $239.01 | 2019 | |
| Pfizer INC. | $213.04 | 2019-2020 | |
| Biotronik Nro, INC. | $211.86 | 2025 | Prospera |
| Saluda Medical Americas, INC. | $152.79 | 2025 | Evoke |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $126.41 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $92.86 | 2021 | |
| Foundation Fusion Solutions, LLC | $59.42 | 2024 | |
| Arbor Pharmaceuticals, INC. | $53.25 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $41.19 | 2019 | |
| Nalu Medical, INC. | $38.24 | 2021-2024 | Nalu Neurostimulation System |
| Tersera Therapeutics LLC | $34.08 | 2019 | |
| Stryker Corporation | $30.63 | 2024 | Mild Device Kit |
| Electronic Waveform Lab, INC. | $24.70 | 2019 | |
| Scilex Pharmaceuticals INC. | $22.42 | 2019 | |
| Si-Bone, INC. | $17.73 | 2019 | |
| Medtronic USA, INC. | $16.14 | 2019 | |
| Forte Bio-Pharma LLC | $16.05 | 2019 | |
| Relievant Medsystems, INC. | $15.16 | 2023 | Intracept |
| Sentynl Therapeutics, INC. | $13.90 | 2019 | |
| Depuy Synthes Sales INC. | $13.14 | 2019 | |
| Shionogi INC | $13.13 | 2019 | |
| Supernus Pharmaceuticals, INC. | $11.99 | 2019 | |
| Zyla Life Sciences, INC. | $11.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Uplekh Purewal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.